Filter announcements
Loading...
IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.
IOL Chemicals and Pharmaceuticals Limited has hosted a business update conference call with investors and analysts. The company has made the audio recording of this strategic interaction accessible on its official website for stakeholders seeking updates on business operations and performance insights.
IOL Chemicals and Pharmaceuticals Limited has announced a virtual group conference call with investors and analysts to discuss recent business developments and strategic growth initiatives.
IOL Chemicals is expanding its Ibuprofen capacity by 6,000 MTPA to 18,000 MTPA with a ₹350 Cr investment. It is also entering the CDMO formulation space with a ₹110 Cr facility and establishing a dedicated specialty chemicals plant for ₹35 Cr, entirely funded via internal accruals.
Submission of Voting Results along with Scrutinizer s Report with regard to the 39th Annual General Meeting of the Company
IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 02, 2026